Cancer cells with up-regulated PD-L1 would not only inactivate PD-1-expressing T cells, but will also show increased resistance to IFN-mediated apoptosis through reverse signaling by PD-L1 within cancer cells (Gato-Canas et al., 2017; Jalali et al., 2019). The gene discussed is CD274; the disease is cancer.